Fig. 2.

Percentage of treatment use in the 12 months post-vitiligo diagnosis. A Patients with no vitiligo treatment prior to diagnosis (N = 13,449)^a. B Patients with moderate-to-severe vitiligo (N = 3462)^b; ^a56.5% received no treatment during follow-up; ^b1.5% received no treatment during follow-up. Surgery (skin grafts) < 0.1%; dermabrasion and monobenzone 0%; Total number sums to > 100% as some patients can have multiple treatments. Moderate-to-severe vitiligo: patients initiating treatment post-vitiligo diagnosis as use of ≥ 1 systemic corticosteroid and/or phototherapy, and/or 3 or more dermatology visits for vitiligo diagnoses in the first 12 months post-index date. CS corticosteroid, HTCS high-potency topical CS, MTCS medium-potency topical CS, LTCS low-potency topical CS, TCI topical calcineurin inhibitors